Cargando…
Cyclooxygenase-2 Expression in Bladder Cancer and Patient Prognosis: Results from a Large Clinical Cohort and Meta-Analysis
Aberrant overexpression of cyclooxygenase-2 (COX2) is observed in urothelial carcinoma of the bladder (UCB). Studies evaluating COX2 as a prognostic marker in UCB report contradictory results. We determined the prognostic potential of COX2 expression in UCB and quantitatively summarize the results w...
Autores principales: | Czachorowski, Maciej J., Amaral, André F. S., Montes-Moreno, Santiago, Lloreta, Josep, Carrato, Alfredo, Tardón, Adonina, Morente, Manuel M., Kogevinas, Manolis, Real, Francisco X., Malats, Núria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3441520/ https://www.ncbi.nlm.nih.gov/pubmed/23028744 http://dx.doi.org/10.1371/journal.pone.0045025 |
Ejemplares similares
-
Integration Analysis of Three Omics Data Using Penalized Regression Methods: An Application to Bladder Cancer
por: Pineda, Silvia, et al.
Publicado: (2015) -
Total Fluid and Water Consumption and the Joint Effect of Exposure to Disinfection By-Products on Risk of Bladder Cancer
por: Michaud, Dominique S., et al.
Publicado: (2007) -
Genetic Variation in the TP53 Pathway and Bladder Cancer Risk. A Comprehensive Analysis
por: Pineda, Silvia, et al.
Publicado: (2014) -
CD8+ Cytotoxic Immune Infiltrate in Non-Muscle Invasive Bladder Cancer: A Standardized Methodology to Study Association with Clinico-Pathological Features and Prognosis
por: Masson-Lecomte, Alexandra, et al.
Publicado: (2019) -
Large-Scale Evaluation of Candidate Genes Identifies Associations between VEGF Polymorphisms and Bladder Cancer Risk
por: García-Closas, Montserrat, et al.
Publicado: (2007)